To verify the performance of our system in tissue biomarker analysis, the selected concentrations of HER2 Abs (0.750× for LOTs #1 and #3, 1.000× for LOT #2) were used for the immunostaining of real human tissue sections from breast cancer patients. Here, ERBB2 is linked to breast carcinoma.